drugset / Trial / NCT01006161
Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)
RandomizedParallel-groupDouble-blindTreatment
Summary
Given the strong inhibition of SCH 527123 on neutrophil migration to sites of inflammation, there is a theoretical reason for its use in patients with severe asthma where neutrophils are thought to play a significant role in the pathophysiology of the disease.
Timeline
- Start
- 2010-01
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NAVARIXIN ANHYDROUS | Small molecule | — | — |